NRF1 and cancer: NRF1 inhibition sensitizes cancer cells to proteasome inhibitors, suggesting that the suppression of NRF1 activity may have a synergizing effect with proteasome inhibitors for the treatment of cancer patients exhibiting elevated proteasome activities [25].